John Zehner is the President and CEO of SpectronRx, where they provide GMP grade isotopes and contract manufacturing services since 2018. Their extensive experience includes leadership roles as President and COO at IBA and COO at Eastern Isotopes Inc, along with consulting for Zevacor's radiopharmaceutical business strategy. Additionally, they serve as CEO and President of NukeMed, focusing on regulatory support and business strategies in Nuclear Medicine. John holds a Bachelor's degree in Pharmacy from Purdue University, earned in 1991.